Medplus Health Services quarterly results

Q2 FY27 · Jul–Sep 2026

₹ crore	Q2 FY27	Q2 FY26	Change
Revenue	2,037	1,679	+21.3%
EBITDA	170	149	+14.2%
EBITDA margin	8.4%	8.9%	−0.5 pts
Profit before tax	70.1	68.9	+1.8%
Net profit	56.1	55.5	+1.0%
EPS	₹4.73	₹4.63	+2.2%

Every quarter

₹ crore except per share

Tap a line for its trend	Q2 FY27Sep 2026	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025	Q4 FY25Mar 2025	Q3 FY25Dec 2024	Q2 FY25Sep 2024	Q1 FY25Jun 2024	Q4 FY24Mar 2024	Q3 FY24Dec 2023	Earlier quartersAlpha Plus

Expenses
	2,037	1,880	1,864	1,806	1,679	1,543	1,510	1,561	1,576	1,489	1,490	1,441	Earlier quartersEvery year the company has filed comes with Alpha Plus.
	20.5	19.8	20.6	18.2	17.5	15.0	15.8	12.5	11.6	8.7	10.5	9.8
	2,058	1,899	1,885	1,824	1,697	1,558	1,525	1,574	1,588	1,498	1,501	1,451
	21.3	20.7	25.6	20.5	23.4	19.2	19.5	14.2	15.6	12.4	12.2	12.5
	1,589	1,459	1,395	1,362	1,221	1,053	1,137	1,107	1,083	1,246	1,163	1,152
	−83.7	−60.4	−49.8	−48.3	−4.1	67.6	−47.6	49.4	103	−98.7	−21.7	−42.1
	250	242	238	233	213	200	194	190	180	162	161	160
	36.6	33.3	33.5	30.8	28.8	27.4	26.8	26.0	25.1	24.7	25.1	24.5
	83.8	77.9	75.9	72.7	68.6	65.6	64.2	62.5	63.1	60.0	59.2	57.1
	90.8	85.2	86.2	81.2	76.9	71.7	70.4	68.7	69.5	73.7	70.1	67.4
	1,988	1,858	1,805	1,751	1,628	1,505	1,464	1,517	1,540	1,480	1,469	1,431
	170	133	169	159	149	131	136	133	124	93.8	106	91.8
	86.2	55.3	93.2	85.9	80.3	65.1	72.2	70.1	61.3	33.7	46.7	34.7
Profit
	70.1	41.9	80.3	73.3	68.9	52.8	61.1	56.6	47.8	17.8	32.0	20.0
	70.1	41.9	80.3	73.3	68.9	52.8	61.1	56.6	47.8	17.8	32.0	20.0
	19.1	11.5	22.4	20.7	20.2	14.4	12.7	15.5	13.7	6.0	8.7	9.8
	−5.0	−2.8	−6.0	−5.2	−6.8	−4.0	−2.9	−4.8	−4.6	−2.6	−10.3	−3.5
	14.1	8.7	16.4	15.5	13.4	10.4	9.8	10.7	9.1	3.4	−1.6	6.3
	56.1	33.2	64.0	57.8	55.5	42.3	51.3	45.9	38.7	14.3	33.6	13.7
	56.1	33.2	64.0	57.8	55.5	42.3	51.3	45.9	38.7	14.3	33.6	13.7
	0.7	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	−3.6	1.3
	56.8	33.2	66.1	57.8	55.5	42.3	51.5	45.9	38.7	14.3	30.0	15.0
	56.1	33.2	64.0	57.8	55.5	42.4	51.3	45.9	38.7	14.4	33.4	13.7
	−0.0	−0.0	−0.0	−0.0	0.0	0.0	−0.0	−0.0	−0.0	−0.0	0.2	−0.0
Per share
	₹4.73	₹2.76	₹5.33	₹4.82	₹4.63	₹3.54	₹4.32	₹3.84	₹3.24	₹1.20	₹2.81	₹1.15
	₹4.72	₹2.76	₹5.33	₹4.81	₹4.62	₹3.53	₹4.30	₹3.82	₹3.23	₹1.20	₹2.79	₹1.14
Other comprehensive income — detail
	0.7	0.0	2.2	0.0	0.0	—	0.1	—	—	—	—	—
	0.8	—	2.7	—	—	—	0.2	—	—	—	−4.4	1.6
	0.1	0.0	0.5	0.0	0.0	—	0.1	—	—	—	—	—
	—	—	—	—	—	—	—	—	—	0.0	−0.8	0.3
	56.8	33.2	66.2	57.8	55.5	42.4	51.5	45.9	38.7	14.4	29.8	15.0
	−0.0	−0.0	−0.0	−0.0	0.0	0.0	−0.0	−0.0	−0.0	−0.0	0.2	−0.0
Per share — as-filed variants
	₹4.73	₹2.76	₹5.33	₹4.82	₹4.63	₹3.54	₹4.32	₹3.84	₹3.24	₹1.20	₹2.81	₹1.15
	₹4.72	₹2.76	₹5.33	₹4.81	₹4.62	₹3.53	₹4.30	₹3.82	₹3.23	₹1.20	₹2.79	₹1.14
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	511	460	493	472	439	403	401	391	374	329	337	319
	25.1%	24.5%	26.5%	26.2%	26.1%	26.1%	26.6%	25.0%	23.7%	22.1%	22.6%	22.1%
Adjusted (ex-exceptional items) — derived
	70.1	41.9	80.3	73.3	68.9	52.8	61.1	56.6	47.8	17.8	32.0	20.0
	56.1	33.2	64.0	57.8	55.5	42.3	51.3	45.9	38.7	14.3	33.6	13.7
	₹4.73	₹2.76	₹5.33	₹4.82	₹4.63	₹3.54	₹4.32	₹3.84	₹3.24	₹1.20	₹2.81	₹1.15

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDPLUS₹598.05

Medplus Health Services Ltd.

· Consumer Services

Annual Quarterly₹ CrorePeersAPOLLOHOSP MANYAVAR MSTCLTD NESCO JUSTDIAL JSLL QUESS IXIGOMcap ₹7,180 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q3 FY24 31/12/2023	Q4 FY24 31/03/2024	Q1 FY25 30/06/2024	Q2 FY25 30/09/2024	Q3 FY25 31/12/2024	Q4 FY25 31/03/2025	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026	Q2 FY27 30/09/2026
Revenue from Operations	1,441.5	1,490.5	1,488.8	1,576.2	1,561.4	1,509.6	1,542.6	1,679.3	1,806.1	1,864.4	1,879.6	2,037.1
Other Income	9.8	10.5	8.7	11.6	12.5	15.8	15.0	17.5	18.2	20.6	19.8	20.5
Total Income	1,451.3	1,501.0	1,497.5	1,587.8	1,574.0	1,525.4	1,557.7	1,696.8	1,824.4	1,885.0	1,899.4	2,057.7
Expenses
+ Cost of Materials Consumed	12.5	12.2	12.4	15.6	14.2	19.5	19.2	23.4	20.5	25.6	20.7	21.3
+ Purchases of Stock-in-Trade	1,152.3	1,163.3	1,245.8	1,083.0	1,106.9	1,136.7	1,052.9	1,220.9	1,361.5	1,395.1	1,459.0	1,588.7
+ Changes in Inventories	-42.1	-21.7	-98.7	103.3	49.4	-47.6	67.6	-4.1	-48.3	-49.8	-60.4	-83.7
+ Employee Benefit Expense	159.5	160.6	161.8	180.3	189.7	194.2	200.4	213.3	232.6	238.1	241.9	250.0
+ Finance Costs	24.5	25.1	24.7	25.1	26.0	26.8	27.4	28.8	30.8	33.5	33.3	36.6
+ Depreciation & Amortisation	57.1	59.2	60.0	63.1	62.5	64.2	65.6	68.6	72.7	75.9	77.9	83.8
+ Other Expenses	67.4	70.1	73.7	69.5	68.7	70.4	71.7	76.9	81.2	86.2	85.2	90.8
Total Expenses	1,431.3	1,469.0	1,479.8	1,540.0	1,517.4	1,464.3	1,504.9	1,627.9	1,751.1	1,804.6	1,857.5	1,987.5
EBITDA	91.8	105.9	93.8	124.4	132.5	136.4	130.7	148.8	158.6	169.2	133.2	170.1
EBIT	34.7	46.7	33.7	61.3	70.1	72.2	65.1	80.3	85.9	93.2	55.3	86.2
Profit
PBT before Exceptional Items	20.0	32.0	17.8	47.8	56.6	61.1	52.8	68.9	73.3	80.3	41.9	70.1
Pretax Income	20.0	32.0	17.8	47.8	56.6	61.1	52.8	68.9	73.3	80.3	41.9	70.1
+ Current Tax	9.8	8.7	6.0	13.7	15.5	12.7	14.4	20.2	20.7	22.4	11.5	19.1
+ Deferred Tax	-3.5	-10.3	-2.6	-4.6	-4.8	-2.9	-4.0	-6.8	-5.2	-6.0	-2.8	-5.0
Tax Expense	6.3	-1.6	3.4	9.1	10.7	9.8	10.4	13.4	15.5	16.4	8.7	14.1
Net Income	13.7	33.6	14.3	38.7	45.9	51.3	42.3	55.5	57.8	64.0	33.2	56.1
+ Net Income — Continuing Ops	13.7	33.6	14.3	38.7	45.9	51.3	42.3	55.5	57.8	64.0	33.2	56.1
+ Other Comprehensive Income	1.3	-3.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.7
Total Comprehensive Income	15.0	30.0	14.3	38.7	45.9	51.5	42.3	55.5	57.8	66.1	33.2	56.8
Net Income to Common	13.7	33.4	14.4	38.7	45.9	51.3	42.4	55.5	57.8	64.0	33.2	56.1
Minority Interest	-0.0	0.2	-0.0	-0.0	-0.0	-0.0	0.0	0.0	-0.0	-0.0	-0.0	-0.0
Per Share
Basic EPS	1.15	2.81	1.20	3.24	3.84	4.32	3.54	4.63	4.82	5.33	2.76	4.73
Diluted EPS	1.14	2.79	1.20	3.23	3.82	4.30	3.53	4.62	4.81	5.33	2.76	4.72
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	—	—	—	0.1	—	0.0	0.0	2.2	0.0	0.7
+ Items NOT to be Reclassified to P&L	1.6	-4.4	—	—	—	0.2	—	—	—	2.7	—	0.8
+ Tax on Items NOT to be Reclassified	—	—	—	—	—	0.1	—	0.0	0.0	0.5	0.0	0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.3	-0.8	0.0	—	—	—	—	—	—	—	—	—
Comprehensive Income — Owners of Parent	15.0	29.8	14.4	38.7	45.9	51.5	42.4	55.5	57.8	66.2	33.2	56.8
Comprehensive Income — Non-controlling Interests	-0.0	0.2	-0.0	-0.0	-0.0	-0.0	0.0	0.0	-0.0	-0.0	-0.0	-0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	1.15	2.81	1.20	3.24	3.84	4.32	3.54	4.63	4.82	5.33	2.76	4.73
Diluted EPS — Continuing Operations	1.14	2.79	1.20	3.23	3.82	4.30	3.53	4.62	4.81	5.33	2.76	4.72
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	318.7	336.6	329.3	374.3	390.9	401.0	402.9	439.1	472.4	493.4	460.3	510.8
Gross Margin %	22.11	22.58	22.12	23.75	25.03	26.56	26.12	26.15	26.16	26.47	24.49	25.08
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	20.0	32.0	17.8	47.8	56.6	61.1	52.8	68.9	73.3	80.3	41.9	70.1
Net Income Adj (tax-effected)	13.7	33.6	14.3	38.7	45.9	51.3	42.3	55.5	57.8	64.0	33.2	56.1
EPS Adj	1.15	2.81	1.20	3.24	3.84	4.32	3.54	4.63	4.82	5.33	2.76	4.73
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	23.9	23.9	23.9	23.9	23.9	23.9	23.9	24.0	24.0	24.0	24.0	24.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q2 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Medplus Health Services Q2 FY27 results (July–September 2026)

Medplus Health Services (NSE: MEDPLUS) reported its Q2 FY27 results (July–September 2026). Consolidated net profit was ₹56.1 crore, up 1.0% from ₹55.5 crore in Q2 FY26 and up 69.0% from ₹33.2 crore in Q1 FY27. Revenue from operations was ₹2,037 crore, up 21.3% year on year and up 8.4% from the previous quarter.

Q3 FY27 results due by: 14 February 2027

Q2 FY27 at a glance · consolidated

Net profit: ₹56.1 Cr+1.0% vs Q2 FY26+69.0% vs Q1 FY27
Revenue from operations: ₹2,037 Cr+21.3% vs Q2 FY26+8.4% vs Q1 FY27
Operating margin (EBIT): 4.2%−0.5 pts vs Q2 FY26+1.3 pts vs Q1 FY27EBIT ₹86.2 Cr
EBITDA: ₹170 Cr+14.2% vs Q2 FY26+27.6% vs Q1 FY27margin 8.3%
Earnings per share (basic): ₹4.73+2.2% vs Q2 FY26+71.4% vs Q1 FY27
Net profit margin: 2.8%−0.6 pts vs Q2 FY26+1.0 pts vs Q1 FY27

Questions

What was Medplus Health Services' net profit in Q2 FY27?

Consolidated net profit was ₹56.1 crore, up 1.0% from ₹55.5 crore in Q2 FY26 and up 69.0% from ₹33.2 crore in Q1 FY27.

What was Medplus Health Services' revenue in Q2 FY27?

Revenue from operations was ₹2,037 crore, up 21.3% year on year and up 8.4% from the previous quarter.

What was Medplus Health Services' operating margin in Q2 FY27?

Operating profit (EBIT — revenue less operating expenses, before finance costs and other income) was ₹86.2 crore, a margin of 4.2%, against 2.9% in Q1 FY27 and 4.8% in Q2 FY26. EBITDA was ₹170 crore, 8.3% of revenue.

How were Medplus Health Services' Q2 FY27 results?

Both grew from a year earlier: net profit was up 1.0% at ₹56.1 crore and revenue was up 21.3% at ₹2,037 crore. The operating margin was 4.2%, down 0.5 percentage points from 4.8% a year earlier. Against Q1 FY27, net profit was up 69.0% and revenue up 8.4%.

What was Medplus Health Services' net profit in the first half of FY27?

Consolidated net profit for the first half of FY27 (April–September 2026) was ₹89.3 crore, down 8.8% from ₹97.9 crore in the same months a year earlier. Revenue from operations was ₹3,917 crore, up 21.6%.

What is Medplus Health Services' net profit margin?

Medplus Health Services' net profit margin was 2.8% in Q2 FY27 (net profit as a share of revenue from operations), against 3.3% in Q2 FY26 (down 0.6 percentage points). For FY26 as a whole it was 3.2%.

What was Medplus Health Services' EPS in Q2 FY27?

Basic earnings per share were ₹4.73, against ₹4.63 in Q2 FY26.

What was Medplus Health Services' net profit in FY26?

Consolidated net profit was ₹220 crore in FY26 (April 2025–March 2026), up 46.1% from ₹150 crore in FY25. It was ₹65.5 crore in FY24 and ₹49.8 crore in FY23: up 341.4% over three years, 64.0% a year on average.

What was Medplus Health Services' revenue in FY26?

Revenue from operations was ₹6,892 crore in FY26 (April 2025–March 2026), up 12.3% from ₹6,136 crore in FY25. It was ₹5,625 crore in FY24 and ₹4,558 crore in FY23: up 51.2% over three years, 14.8% a year on average.

How has Medplus Health Services' profit changed over the last four quarters?

Net profit by quarter: ₹57.8 crore in Q3 FY26, ₹64 crore in Q4 FY26, ₹33.2 crore in Q1 FY27 and ₹56.1 crore in Q2 FY27. That is ₹211 crore over the four quarters, up 8.2% from ₹195 crore in the four quarters before. Revenue from operations: ₹1,806 crore, ₹1,864 crore, ₹1,880 crore and ₹2,037 crore.

When will Medplus Health Services announce its Q3 FY27 results?

Q3 FY27 covers October–December 2026. Listed companies must publish quarterly results within 45 days of the quarter's end (SEBI listing rules, Regulation 33), so the results are due by 14 February 2027. The company tells the exchanges the date of the board meeting at least two working days before it.

Where do these Medplus Health Services figures come from?

From Medplus Health Services' own consolidated results filings to NSE, in ₹ crore as filed. Growth compares the same consolidated figures a year and a quarter earlier.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.